Insulin activation of phosphatidylinositol 3-kinase in human skeletal muscle in vivo

Journal of Applied Physiology

Volumn 83, Issue 3, 1997, Pages 718-722

  Hickey, Matthew S ^a,b   Tanner, Charles J ^a   O'Neill, D Sean ^a   Morgan, Lydia J ^a   Dohm, G Lynis ^a   Houmard, Joseph A ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

^b Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

Glucose; Insulin signaling; Muscle biopsy

Indexed keywords

GLUCOSE; INSULIN; PHOSPHATIDYLINOSITOL KINASE;

ADULT; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; GLUCOSE TOLERANCE TEST; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; INSULIN METABOLISM; INSULIN RELEASE; INSULIN SENSITIVITY; MALE; NEEDLE BIOPSY; NORMAL HUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

EID: 0030801342     PISSN: 87507587     EISSN: None     Source Type: Journal    
DOI: 10.1152/jappl.1997.83.3.718     Document Type: Article

References (29)

1. Ader, M., and R. N. Bergman. Importance of transcapillary insulin transport to dynamics of insulin action after intravenous glucose. Am. J. Physiol. 266 (Endocrinol. Metab. 29): E17-E25, 1994.
2. Bergman, R. N., D. T. Finegood, and M. Ader. Assessment of insulin sensitivity in-vivo. Endocr. Rev. 6: 45-86, 1985.
3. Bjornholm, M., Y. Kawano, M. Lehtihet, and J. R. Zierath. Insulin receptor substrate-1 phosphorylation and phosphatidylinositol 3-kinase activity in skeletal muscle from NIDDM subjects after in-vivo insulin stimulation. Diabetes 46: 524-527, 1997.
4. Bonini, J. A., J. R. Colca, C. Dailey, M. White, and C. Hoffman. Compensatory alterations for insulin signal transduction and glucose transport in insulin-resistant diabetes. Am. J. Physiol. 269 (Endocrinol. Metab. 32): E759-E765, 1995.
5. Carvalho, C. R. O., S. L. Brenelli, A. C. Silva, A. L. B. Nunes, L. A. Velloso, and M. J. A. Saad. Effect of aging on insulin receptor, insulin receptor substrate-1, and phosphatidylinositol 3-kinase in liver and muscle of rats. Endocrinology 137: 151-159, 1996.
6. Cheatham, B., and C. R. Kahn. Insulin action and the insulin signaling network. Endocr. Rev. 16: 117-142, 1995.
7. Cuatrecasas, P. Insulin-receptor interactions in adipose cells: direct measurement and properties. Proc. Natl. Acad. Sci. USA 68: 1264-1268, 1971.
8. Czech, M. P. The molecular basis of insulin action. Annu. Rev. Biochem. 46: 359-384, 1977.
9. DeFronzo, R. A., and E. Ferranninni. Insulin resistance. A multifactorial syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14: 173-194, 1991.
10. DeFronzo, R. A., J. D. Tobin, and R. Andres. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am. J. Physiol. 237 (Endocrinol. Metab. Gastrointest. Physiol. 6): E214-E223, 1979.
11. Folli, F., M. J. A. Saad, J. M. Backer, and C. R. Kahn. Regulation of phosphatidylinositol 3-kinase activity in liver and muscle of animal models of insulin-resistant and insulin-deficient diabetes mellitus. J. Clin. Invest. 92: 1787-1794, 1993.
12. Folli, F., M. J. A. Saad, J. M. Backer, and C. R. Kahn. Insulin stimulation of phosphatidylinositol 3-kinase activity and association with insulin receptor substrate-1 in liver and muscle of the intact rat. J. Biol. Chem. 267: 22171-22177, 1992.
13. Freidenberg, G. R., S. Suter, R. R. Henry, J. Nolan, D. Reichart, and J. M. Olefsky. Delayed onset of insulin activation of the insulin receptor kinase in vivo in human skeletal muscle. Diabetes 43: 118-126, 1994.
14. Goodyear, L. J., F. Giorgino, T. W. Balon, G. Condorelli, and R. J. Smith. Effects of contractile activity on tyrosine phosphoproteins and PI3-kinase activity in rat skeletal muscle. Am. J. Physiol. 268 (Endocrinol. Metab. 31): E987-E995, 1995.
15. Goodyear, L. J., F. Giorgino, L. A. Sherman, J. Carey, R. J. Smith, and G. L. Dohm. Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese patients. J. Clin. Invest. 95: 2195-2204, 1995.
16. Hadari, Y. R., E. Tzahar, O. Nadiv, P. Rothenberg, C. T. Roberts, Jr., D. LeRoith, Y. Yarden, and Y. Zick. Insulin and insulinomimetic agents induce activation of phosphatidylinositol 3-kinase upon its association with pp185 (IRS-1) in intact rat livers. J. Biol. Chem. 267: 17483-17486, 1992.
17. Heller-Harrison, R. A., M. Morin, A. Guilherme, and M. P. Czech. Insulin-mediated targeting of phosphatidylinositol 3-kinase to GLUT4-containing vesicles. J. Biol. Chem. 271: 10200-10204, 1996.
18. Heydrick, S. J., D. Jullien, N. Gautier, J.-F. Tanti, S. Giorgetti, E. Van Obberghen, and Y. Le Marchand-Brustel. Defect in skeletal muscle phosphatidylinositol 3-kinase in obese, insulin resistant mice. J. Clin. Invest. 91: 1358-1366, 1993.
19. Hickey, M. S., M. D. Weidner, K. E. Gavigan, D. Zheng, G. L. Tyndall, and J. A. Houmard. The insulin action-fiber type relationship in humans is muscle group-specific. Am. J. Physiol. 269 (Endocrinol. Metab. 32): E150-E154, 1995.
20. Jansson, P.-A. E., J. P. Fowelin, H. P. Von Schneck, U. P. Smith, and P. N. Lonnroth. Measurement by microdialysis of the insulin concentration in subcutaneous interstitial fluid. Importance of the endothelial barrier for insulin. Diabetes 42: 1469-1473, 1993.
21. Kasuga, M., F. A. Karlsson, and C. R. Kahn. Insulin stimulates the phosphorylation of the 95,000-dalton subunit of its own receptor. Science 215: 185-187, 1982.
22. Laville, M., D. Auboeuf, Y. Khalfallah, N. Vega, J. P. Riou, and H. Vidal. Acute regulation by insulin of phosphatidylinositol 3-kinase, Rad, Glut 4, and lipoprotein lipase mRNA levels in human muscle. J. Clin. Invest. 98: 43-49, 1996.
23. Lee, A. D., P. A. Hansen, and J. O. Holloszy. Wortmannin inhibits insulin-stimulated but not contraction stimulated glucose transport activity in skeletal muscle. FEBS Lett. 361: 51-54, 1995.
24. Martin, S. S., T. Haruta, A. J. Morris, A. Klippel, L. T. Williams, and J. M. Olefsky. Activated phosphatidylinositol 3-kinase is sufficient to mediate actin rearrangement and GLUT-4 translocation in 3T3-L1 adipocytes. J. Biol. Chem. 271: 17605-17608, 1996.
25. Okada, T., Y. Kawano, T. Sakakibara, O. Hazeki, and M. Ui. Essential role of phosphatidylinositol 3-kinase in insulin-induced glucose transport and antilipolysis in rat adipocytes. J. Biol. Chem. 269: 3568-3573, 1994.
26. Pollock, M. L., D. H. Schmidt, and A. S. Jackson. Measurement of cardiorespiratory fitness and body composition in the clinical setting. Compr. Ther. 6: 12-27, 1980.
27. Saad, M. J. A., F. Folli, J. A. Kahn, and C. R. Kahn. Modulation of insulin receptor, insulin receptor substrate-1, and phosphatidylinositol 3-kinase in liver and muscle of dexamethasone-treated rats. J. Clin. Invest. 92: 2065-2072, 1993.
28. White, M. F., R. Maron, and C. R. Kahn. Insulin rapidly stimulates tyrosine phosphorylation of a MR 185,000 protein in intact cells. Nature 318: 183-186, 1985.
29. Yang, J., J. F. Clark, C. J. Ester, P. W. Young, M. Kasuga, and G. D. Holman. Phosphatidylinositol 3-kinase acts at an intracellular membrane site to enhance GLUT4 exocytosis in 3T3-L1 cells. Biochem. J. 313: 125-131, 1996.